NOVABAY PHARMACEUTICALS INC's ticker is NBY and the CUSIP is 66987P201. A total of 10 filers reported holding NOVABAY PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 46,903 | $34,000 | 0.01% |
| TOWNSQUARE CAPITAL LLC | 53,672 | $40,000 | 0.00% |
| NVWM, LLC | 2,997 | $2,000 | 0.00% |
| VANGUARD GROUP INC | 152,309 | $111,000 | 0.00% |
| UBS Group AG | 2,000 | $1,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $18,000 | 0.00% |
| Sugarloaf Wealth Management, LLC | 2,000 | $1,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 5,260 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 3,000 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 7,514 | $5,000 | 0.00% |